Continuum Advisory LLC Raises Stake in CVS Health Corporation $CVS

Continuum Advisory LLC grew its holdings in CVS Health Corporation (NYSE:CVS) by 11.2% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 76,148 shares of the pharmacy operator’s stock after buying an additional 7,639 shares during the period. Continuum Advisory LLC’s holdings in CVS Health were worth $5,741,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Harbor Capital Advisors Inc. lifted its position in CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares during the period. Avion Wealth raised its stake in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the second quarter worth $30,000. Bell Investment Advisors Inc grew its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Finally, Front Row Advisors LLC increased its stake in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 371 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several recent analyst reports. Barclays raised their target price on shares of CVS Health from $87.00 to $93.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 10th. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Raymond James Financial boosted their target price on CVS Health from $75.00 to $90.00 in a research report on Friday, October 31st. TD Cowen raised their price target on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Finally, Sanford C. Bernstein upped their price objective on CVS Health from $86.00 to $87.00 and gave the stock a “market perform” rating in a report on Friday, December 12th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $94.67.

CVS Health Stock Performance

Shares of CVS stock opened at $79.96 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. The firm has a market capitalization of $101.50 billion, a price-to-earnings ratio of 210.41, a price-to-earnings-growth ratio of 0.79 and a beta of 0.48. CVS Health Corporation has a one year low of $43.65 and a one year high of $85.15. The company has a 50 day moving average price of $78.86 and a 200 day moving average price of $73.11.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. CVS Health’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.